Lv1
20 积分 2024-03-11 加入
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
11小时前
待确认
Nationwide gastric cancer prevention in China, 2021–2035: a decision analysis on effect, affordability and cost-effectiveness optimisation
7个月前
已完结
Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer
7个月前
已完结
Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer
7个月前
已完结
Cost-Effectiveness Analysis: Selective Use of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
7个月前
已完结
Cost-Effectiveness of Adjuvant Chemotherapy in the Treatment of Early-Stage Colon Cancer
7个月前
已完结
皖公网安备34019202002308
